Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000130678 | SCV000185564 | uncertain significance | Hereditary cancer-predisposing syndrome | 2014-01-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000588328 | SCV000222214 | uncertain significance | not provided | 2022-11-14 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Also known as c.-868G>C |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001526858 | SCV000696543 | uncertain significance | not specified | 2021-05-19 | criteria provided, single submitter | clinical testing | Variant summary: PTEN c.-869G>C (refseq HGVScdot: c.-868G>C) is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 6.4e-05 in 31192 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.-869G>C in individuals affected with Cowden Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Three ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Fulgent Genetics, |
RCV000763682 | SCV000894562 | uncertain significance | Macrocephaly-autism syndrome; Familial meningioma; Malignant tumor of prostate; VACTERL with hydrocephalus; Glioma susceptibility 2; PTEN hamartoma tumor syndrome; Cowden syndrome 1 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV004700442 | SCV001138117 | likely benign | Hereditary cancer | 2024-09-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following: it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease, and/or has normal protein function, and/or has lack of segregation with disease, and/or has been detected in co-occurrence with known pathogenic variant, and/or has lack of disease association in case-control studies, and/or is located in a region inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV001526858 | SCV002065791 | uncertain significance | not specified | 2019-04-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000588328 | SCV002497058 | likely benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing | PTEN: BS1 |